| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in RYTM over the last quarter tilts toward selling: insiders offloaded a net 258,450 shares worth roughly $28.8M.
RYTM sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 239.3K | $1.45M | - | |
| CFO | 114.0K | $11.93M | - | |
| VP | 55.7K | $6.54M | - | |
| Other | 29.4K | - | - | |
| Other | 15.9K | $1.91M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2020 | Ra Capital Management, L.P.52 | 10% Owner | Sell | 150,323 | $23.05 | $3,465,614.60 | -2.8% | |
| Jun 26, 2020 | Foley Todd82 | Director | Sell | 300 | $25.04 | $7,512.00 | - | |
| Jun 25, 2020 | Foley Todd82 | Director | Sell | 115,335 | $25.35 | $2,923,845.19 | -5.7% | |
| Jun 5, 2020 | Foley Todd82 | Director | Sell | 1,896 | $20.00 | $37,920.00 | - | |
| Jun 3, 2020 | Foley Todd82 | Director | Sell | 44,358 | $20.21 | $896,511.89 | -2.1% | |
| May 28, 2020 | Foley Todd82 | Director | Sell | 29,300 | $20.17 | $590,958.12 | -1.4% | |
| May 26, 2020 | Foley Todd82 | Director | Sell | 96,921 | $20.32 | $1,969,194.15 | -4.4% | |
| May 20, 2020 | Foley Todd82 | Director | Sell | 34,509 | $20.00 | $690,285.27 | -1.5% | |
| May 13, 2020 | Foley Todd82 | Director | Sell | 1,837 | $20.04 | $36,813.48 | - | |
| May 12, 2020 | Foley Todd82 | Director | Sell | 53,130 | $20.25 | $1,076,063.01 | -2.3% |